We will exhibit at the 19th Annual Meeting of the Japanese Society for Regenerative Medicine.

Materials for regenerative medicine products have been confirmed as suitable! It is easy to freeze and store various types of cells, including hematopoietic stem cells.

"CP-1 High Grade" is a cryoprotectant solution for cells. It allows for the easy cryopreservation of various cells, including mesenchymal stem cells and hematopoietic stem cells. It is a cryopreservation solution that can withstand dry ice transport. 【Features】 ■ Over 25 years of usage experience since 1992 ■ Numerous published papers ■ Non-clinical trials completed, MF registered ■ Manufactured at our GMP-compliant facility in Japan ■ Can be cryopreserved at -80°C ■ Composition disclosed, free of animal-derived materials *For more details, please contact us or refer to the catalog.

• reagent
• Other bio-related products and services

This is a cryopreservation solution suitable for slow freezing of human iPS/ES cells!

By combining it with the cell dispersion solution "Pronase/EDTA for Stem," a high survival rate can be achieved. The composition is clear, so you can use it with confidence. 【Features】 ■ Enables cryopreservation of various cells, including human iPS/ES cells ■ Usable for human iPS cells cultured without feeders ■ Allows cryopreservation with a small number of cells ■ Reduces differentiation risk by keeping DMSO concentration at 5% ■ Free from animal-derived materials 【Examples of cells that can be preserved with CP-5E】 ■ Human iPS cell lines (253G1, 201B7*) ■ Human ES cell lines (KhES-1*, H1) ■ Mouse adipocyte precursor cell line (3T3-L1*) ■ Human pancreatic cancer cell line (PANC-1) ■ Primate kidney-derived cell line (COS-7) ■ Human fetal lung-derived fibroblast cell line (WI-38) ■ Human fetal lung-derived fibroblast cell line (MRC-5) ■ Human fetal kidney-derived cells (HEK-293) ■ Mouse feeder cells (SNL76/7) ■ Human myeloid leukemia cell line (HL-60*) ■ Human NK cell line (NK-92MI) (* Differentiation ability confirmed after freezing and thawing) *For more details, please contact us or refer to the catalog.

• Other research reagents
• reagent
• Other bio-related products and services

Over 40 years of experience and reliability! We will produce culture media according to your specified composition.

At Kyokuto Pharmaceutical Industrial Co., Ltd., we manufacture media with specified compositions for biopharmaceutical production, regenerative medicine, vaccine production, and more. 【Features】 ■ Over 40 years of trust and experience ■ Excellent grinding technology ■ Traceability of raw materials ■ Thorough manufacturing and quality control *For more details, please refer to the catalog or feel free to contact us.

• Culture medium
• Other bio products
• OEM

[Lecturer] Professor Hiroyuki Kato, Faculty of Sociology, Department of Social Policy Science, Hosei University [Key Lecture Content] In this lecture, I will introduce perspectives on the shipbuilding industry. Japan's shipbuilding industry has a long history and can be seen as a "microcosm" of Japanese industry. Within about ten years after World War II, Japan's shipbuilding industry became the world leader in construction volume, and at one point, the construction volume of the seven major domestic companies accounted for more than half of the world's share. Although it has since been surpassed in construction volume by latecomers such as South Korea and China, it still maintains a certain level of competitiveness. Reflecting on the path taken by the shipbuilding industry, which serves as a "microcosm," the reasons for its continued strength, and the challenges it currently faces may provide insights when considering the future of various Japanese industries. [Lecture Items] 1. Characteristics of the shipbuilding industry 2. Shipyards seen through photos and videos 3. The shipbuilding industry depicted in films 4. Why is it still strong? 5. Points to consider for future developments 6. Q&A / Business card exchange

[Speaker] Maho Tanaka, Manager, Strategy Group, Business Consulting Division, Accenture Japan Ltd. [Key Lecture Content] AI is evolving beyond a mere tool for operational efficiency to become an entity responsible for execution, including information acquisition, comparison, judgment, contracts, and purchasing. As actions initiated by dialogues with general-purpose AI chatbots like ChatGPT become mainstream, corporate information is not reaching users directly, and the structure where decision-making and execution are completed on AI is rapidly expanding. In this lecture, based on this irreversible change, we will organize the reality that the competitive axis of companies is shifting from "appealing to consumers" to "how AI understands, selects, and executes." Furthermore, we will explain the key points of strategic transformation that management should consider in the era of agent-based AI, from organizing the information structure cited by AI to designing touchpoints that reclaim the initiative for judgment and execution for the company. [Lecture Items] 1. The impact of AI on information search and access 2. The impact on corporate marketing and communication 3. The ideal direction for corporate communication in the AI era 4. Introduction of our company’s case studies 5. Q&A session

The overall theme of the webinar is: "The Two Barriers Hindering Automation in Food Factories" "Case Studies on Access Control and AI Image Recognition" Our company will be the first to present. For more details, please visit our website!

[Speaker] Yuki Kobayashi, CEO/Co-Founder of MESON Inc. [Key Lecture Content] In this presentation, we will explore "AI glasses," which have recently begun to attract significant attention as the next-generation user interface, explaining their essence and business impact. We will clarify the differences from previous XR devices and organize representative products currently available, while interpreting why AI glasses are becoming a realistic option against the backdrop of the evolution of generative AI and changes in societal acceptance. Furthermore, through market expansion and case studies primarily overseas, we will demonstrate why the years 2026 to 2028 will be a turning point for technology and business, and discuss the issues and risks that Japanese companies should currently address. [Lecture Items] 1. What are AI glasses? 2. Why AI glasses now? 3. Changes happening globally 4. How AI glasses will change work 5. Experience design as a decisive factor 6. The turning point for Japanese companies (Closing) 7. Q&A / Business card exchange *The content of the lecture may change based on the latest trends.

[Speaker] Andy Mochizuki, Director, Deloitte Tohmatsu TMT Division / Monitor Deloitte [Key Lecture Content] In an era where thinking is commoditized by AI, the source of value is determined not by "information" but by "existence," that is, "the meaning of your being." This course will start from the environmental changes surrounding the AI era, exploring the concept of redesigning work in a purpose-driven manner, the type of thinking required in the AI era (QADI cycle), and delving into the absolute differentiating factor that only humans possess—"embodiment." We will update our sense of purpose in the AI era and our collaborative relationship with AI, initiating a transformation to "live anew" from here. [Lecture Items] 1. Mapping Environmental Changes - "From the Era of Information Asymmetry to the Era of Existence Asymmetry" 2. Redesigning Work in a "Purpose-Driven" Manner 3. The "Thinking Models" Necessary in the AI Era 4. The "Body" as an Absolute Differentiating Factor 5. How to "Live Anew" in the Coming AI Era 6. Q&A / Business Card Exchange